Public shortcut

Berry Genomics Co. Ltd. hopes to cut its path to a public listing in half by opting for a reverse merger rather than an IPO.

According to a Dec. 4 regulatory filing, Berry plans to reverse-merge with auto parts company Chengdu Tianxing Instrument & Meter Co. (SZSE:000710) to form a publicly traded gene sequencing company on the Shenzhen Stock Exchange valued at RMB4.3 billion ($618.8 million). The deal is pending approval by the China Securities Regulatory Commission (CSRC). ...